Dade Behring Previews Its Syva Viva-E Drug Testing System at 2004 Meeting of the American Association for Clinical Chemistry
Dade Behring (NASDAQ:DADE) previewed its benchtop Viva-E(TM) Drug Testing System for its Syva(R) product line at the recent meeting of the American Association for Clinical Chemistry (AACC) in Los Angeles. The Viva-E is designed to run Dade Behring’s Syva Emit(R)-branded therapeutic drug monitoring, drugs of abuse and serum toxicology assays, as well as its tests for determining the validity of drug test samples. The product is anticipated to be available in the fourth quarter of 2004.
“Drug testing is an important IVD market, and the pending availability of the Viva-E means another tool in the armament of drug testing, expanding the reach for Dade Behring products and potentially saving lives and contributing to a more productive society,” said Jim Reid-Anderson, Chairman, President and CEO, Dade Behring.
The instrument was developed and is manufactured by Vital Scientific NV, a Netherlands corporation which is a subsidiary of Clinical Data, Inc. (NASDAQ:CLDA); Dade Behring is its sole distributor. “The Viva-E continues the legacy of the established Syva instrument family, which includes the VIVA and V-Twin(TM),” said Kelli Ryzewski, Director, Syva Brand Drug Testing Market.
The instrument is specifically designed for the low- to medium- volume dedicated toxicology laboratory.
Features on the new Viva-E Drug Testing System include:
— Benchtop design
— Throughput of up to 130 Emit(R) tests per hour
— Two reagent capability
— Positive sample identification
— Reagent refrigeration
— Liquid ready-to-use reagents and an extended menu including specimen validity testing
— Capacity for up to 13 methods onboard simultaneously
— Semi-permanent cuvettes for improved walkaway
— Bi-directional host interface, providing two-way communication with hospital LIS systems
Dade Behring’s Syva product line is a global leader in the drugs of abuse testing market, serving both clinical and specialty markets. Outside the clinical laboratory, Syva products are used in criminal justice, occupational health, and on-site employment testing segments, among others.
Dade Behring is a worldwide leader in drug testing, which represents a growing market segment in major countries throughout the world. With 2003 revenues of more than $1.4 billion, Dade Behring is the world’s largest company dedicated solely to clinical diagnostics. It offers a wide range of products, systems and services designed to meet the day-to-day needs of labs, delivering innovative solutions to customers and enhancing the quality of life for patients. Additional company information is available on the Internet at www.dadebehring.com .
